Difficult Airway Management in the Intensive ...

Is the "Cytokine Storm" the Real Killer in ARDS? When a localized lung injury spirals into a systemic catastrophe, we call it a cytokine storm—but are we actually any closer to stopping it, or are we just watching the rain? This deep-dive review, published in the Journal of Inten ...  Show more

Can we break the cycle of Diuretic Resistance? What do you do when the "gold standard" treatment for your congested patient simply stops working? Diuretic resistance (DR) affects up to one-third of patients with heart failure, turning a routine clinical task into a high-stakes ba ...  Show more

Carbon dioxide therapy has become a highly debated and often misunderstood topic. Is elevated CO2 beneficial, or could it pose risks? What exactly are the advantages of CO2 therapy, and how might it impact your health? In this episode, you’ll get to explore the transformative pow ...  Show more

Doctors Lisa and Sara talk to Respiratory Physiotherapist Thomas James about COPD. We start with what COPD is, when to suspect it, a standard work up, pitfalls and points of consideration about spirometry, before moving on to an overview of management. We then cover some chang ...

BSA, MIRD, or voxel-based dosimetry? Join us for part 2 of Dosimetry University where interventional oncologists Dr. Tyler Sandow, Dr. Nima Kokabi, and Dr. Kavi Krishnasamy explore and debate the critical nuances of a successful Y90 procedure, covering dosing methods, lung shunt ...  Show more

In this episode, Dr. Nazim Gherabi (DZ) discusses his systematic review on the treatment of urge incontinence in postmenopausal women.

Dr. Gherabi talks about the most effective therapeutic approaches, and evaluates current evidence. He highlights gaps in research and ...